We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Formylpeptide receptor 1 contributes to epidermal barrier dysfunction-induced skin inflammation through NOD-like receptor C4-dependent keratinocyte activation.
- Authors
Shao, Shuai; Sun, Zhongbin; Chu, Mengyang; Chen, Jiaoling; Cao, Tianyu; Swindell, William R; Bai, Yaxing; Li, Qingyang; Ma, Jingyi; Zhu, Zhenlai; Schuler, Andrew; Helfrich, Yolanda; Billi, Allison C; Li, Zhiguo; Hao, Junfeng; Xiao, Chunying; Dang, Erle; Gudjonsson, Johann E; Wang, Gang
- Abstract
Background Skin barrier dysfunction may both initiate and aggravate skin inflammation. However, the mechanisms involved in the inflammation process remain largely unknown. Objectives We sought to determine how skin barrier dysfunction enhances skin inflammation and molecular mechanisms. Methods Skin barrier defect mice were established by tape stripping or topical use of acetone on wildtype mice, or filaggrin deficiency. RNA-Seq was employed to analyse the differentially expressed genes in mice with skin barrier defects. Primary human keratinocytes were transfected with formylpeptide receptor (FPR)1 or protein kinase R-like endoplasmic reticulum (ER) kinase (PERK) small interfering RNA to examine the effects of these gene targets. The expressions of inflammasome NOD-like receptor (NLR)C4, epidermal barrier genes and inflammatory mediators were evaluated. Results Mechanical (tape stripping), chemical (acetone) or genetic (filaggrin deficiency) barrier disruption in mice amplified the expression of proinflammatory genes, with transcriptomic profiling revealing overexpression of formylpeptide receptor (Fpr1) in the epidermis. Treatment with the FPR1 agonist fMLP in keratinocytes upregulated the expression of the NLRC4 inflammasome and increased interleukin-1β secretion through modulation of ER stress via the PERK-eIF2α-C/EBP homologous protein pathway. The activation of the FPR1-NLRC4 axis was also observed in skin specimens from old healthy individuals with skin barrier defect or elderly mice. Conversely, topical administration with a FPR1 antagonist, or Nlrc4 silencing, led to the normalization of barrier dysfunction and alleviation of inflammatory skin responses in vivo. Conclusions In summary, our findings show that the FPR1-NLRC4 inflammasome axis is activated upon skin barrier disruption and may explain exaggerated inflammatory responses that are observed in disease states characterized by epidermal dysfunction. Pharmacological inhibition of FPR1 or NLRC4 represents a potential therapeutic target.
- Subjects
SKIN inflammation; FILAGGRIN; SMALL interfering RNA; GENE expression; INFLAMMATORY mediators; KERATINOCYTES
- Publication
British Journal of Dermatology, 2024, Vol 190, Issue 4, p536
- ISSN
0007-0963
- Publication type
Article
- DOI
10.1093/bjd/ljad455